Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-market, Randomized, Controlled, Prospective Study Evaluating Intrathecal Pain Medication (IT) Versus Conventional Medical Management (CMM) in the Non-cancer, Refractory, Chronic Pain Population (PROSPER)

NCT04096391 is registered in ClinicalTrials.gov with Evolve Restorative Center as lead sponsor.

NCT NCT04096391
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04096391 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-market, Randomized, Controlled, Prospective Study Evaluating Intrathecal Pain Medication (IT) Versus Conventional Medical Management (CMM) in the Non-cancer, Refractory, Chronic Pain Population (PROSPER)
Lead sponsor
Evolve Restorative Center
Phase
Not applicable
Overall status
Completed
Start date
June 5, 2019
Completion date
April 11, 2022
Enrollment
73 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic nonmalignant pain, pain, chronic, pain, intractable